Divigel

Quick links to important sections

Divigel

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Divigel

Quick Facts

Property Description
Active ingredient Estradiol (as Estradiol Hemihydrate)
Form Transdermal Gel (Semi-solid preparation)
Pharmacological class Hormone Replacement Therapy (HRT) / Estrogen Agonist
Common use Systemic estrogen replacement
Origin Synthetic/Endogenous-identical hormone

What Type of Medication is Divigel?

Divigel is a distinctive prescription-only medication (Rx), primarily functioning as a Systemic estrogen replacement preparation used in Hormone Replacement Therapy (HRT). It is classified as an Estrogen or Estrogen Agonist. This specific formulation is distinguished by its Transdermal Gel form, a unique semi-solid preparation designed for topical application often provided in pre-measured packets or a metered-dose applicator. This delivery method is clinically recognized for facilitating consistent absorption.

As a single-component product, Divigel is an Estrogen monotherapy, meaning it exclusively contains the estrogenic hormone. The transdermal route of administration facilitates systemic delivery to the bloodstream, offering an alternative to oral medications by avoiding extensive initial hepatic metabolism.

Divigel's Composition and General Purpose

The Active ingredient(s) in this preparation is Estradiol, supplied as Estradiol Hemihydrate, a compound structurally identical to 17beta -Estradiol, the principal endogenous hormone naturally produced in the body. As a primary female sex hormone, its structural identity ensures the body utilizes the hormone efficiently. The active ingredient is formulated within a fast-drying hydroalcoholic gel base for ease of application and effective skin penetration.

The overall goal of this specific form of Hormone Replacement Therapy is to provide necessary hormonal supplementation to the body. By replacing the crucial Estradiol, Divigel acts to restore the body's hormonal balance. This fundamental action forms the basis of the therapy's ability to provide a comprehensive Estrogenic effect, commonly utilized in postmenopausal women seeking to address systemic consequences associated with low estrogen levels.

What side effects are possible with Divigel?

Possible Side Effects and Safety Information

The official safety profile for Divigel (Estradiol transdermal gel), consistent with regulatory documents from the FDA and other government authorities, is structured around both common, expected adverse reactions and the serious systemic risks associated with the entire class of systemic estrogen therapy.

Adverse Reactions and Frequency

Adverse reactions documented in clinical trials with an incidence classified as common (greater than 5% and exceeding placebo) include breast tenderness, metrorrhagia (abnormal uterine bleeding), vaginal mycosis, and respiratory tract infections such as nasopharyngitis.

Serious Systemic Risks

Regulatory warnings emphasize serious, low-frequency risks identified in large-scale hormone replacement therapy (HRT) studies. These risks, associated with long-term systemic exposure, primarily involve the cardiovascular and neurological systems, including increased potential for stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Myocardial Infarction (MI). Additionally, the risk of endometrial cancer is a documented concern for women with an intact uterus who are not concurrently receiving a progestin.

Population-Specific Safety Constraints

Official labeling defines specific constraints for use. The medication is contraindicated in individuals with a history of certain conditions, including active thromboembolic disease, breast cancer, or severe hepatic impairment. For women who have not had a hysterectomy, the co-administration of an appropriate progestin is officially required to mitigate the risk of developing endometrial cancer. Furthermore, an increased risk of probable dementia has been documented in postmenopausal women 65 years of age or older in relevant studies.

Application Site Safety

Due to the hydroalcoholic gel base, the official prescribing information includes a safety note that the product is flammable until completely dry. This is an important safety restriction related to the transdermal administration form.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes a specific profile of signs and required actions associated with an overdosage of estradiol gel.

Documented Manifestations

Symptoms recognized by regulatory authorities as manifestations of estrogen overdosage are typically gastrointestinal and endocrine in nature. These can include nausea, vomiting, and abdominal pain. Systemic effects may involve drowsiness or fatigue, and an increase in breast tenderness is also documented. A delayed sign of overexposure is the potential occurrence of withdrawal bleeding, which may appear several days after the excess medication was applied.

Mandated Emergency Action

In the event of suspected overdosage, the prescribing information mandates that the individual seek emergency medical attention right away. The first required response is to discontinue the medication (Divigel) immediately. Contacting a healthcare provider or local Poison Control Center is also required. Treatment is defined as generally symptomatic and supportive, and official documents state that no specific antidote is known for overdosage with this medication.

Overdose Management

Element Regulatory Statement
Required Action Seek emergency medical attention right away and discontinue the medicine.
Treatment Focus Treatment is generally symptomatic and supportive.
Antidote Status No specific antidote is known.

Therapeutic Uses of Divigel

Divigel (Estradiol transdermal gel) is generally applied in contexts involving estrogen deficiency within Hormone Replacement Therapy (HRT) to manage specific, distressing health issues that may arise from a systemic imbalance. The primary therapeutic focus is on addressing symptoms and conditions where low estrogen levels may create noticeable physiological strain. The medication is commonly used to help manage both vasomotor symptoms and genitourinary symptoms of menopause.


Addressing Symptom Burden and Functional Stability

The core therapeutic benefit is the management of moderate to severe vasomotor symptoms (VMS), which include frequent and intense hot flashes and night sweats. This systemic therapy is used for managing the intensity and recurrence of these episodes, which are often disruptive enough to interfere with a patient's sleep and affect functional stability. The medication is commonly applied to help address symptoms related to systemic imbalance associated with low estrogen, offering symptomatic relief for manifestations such as chronic vaginal dryness, irritation, and discomfort during intercourse. For high-risk women, it is also considered relevant in clinical situations requiring the prevention of accelerated bone loss and osteoporosis.

This use may help patients cope more steadily with symptom fluctuations. It is intended to assist with maintaining a sense of stability when symptoms are more noticeable, contributing to improved day-to-day comfort and supporting general well-being during symptomatic periods.


Quick Fact: Symptom Categories Addressed

Category Primary Benefit
Vasomotor Instability Contributes to managing hot flash frequency and intensity.
Genitourinary Symptoms Offers symptomatic relief for chronic dryness and irritation.
Skeletal Health May assist with managing accelerated bone loss in high-risk patients.

Eligibility and Restrictions for Use

Who Can and Cannot Use Divigel?

The eligibility to use Divigel (Estradiol transdermal gel) is strictly regulated by government authorities and is confined to the specific population and conditions outlined in official labeling.

Eligibility Scope

The medicine is primarily approved for use in adult postmenopausal women seeking systemic estrogen replacement. Its use is subject to several absolute contraindications and specific restrictions, reflecting the known risks associated with estrogen monotherapy.

Key Eligibility Classifications

Classification Population/Condition
Allowed Use Adult postmenopausal women.
Contraindicated Known or suspected pregnancy or lactation.
Contraindicated Active or history of venous or arterial thromboembolic disease (e.g., DVT, stroke).
Contraindicated Estrogen-dependent neoplasia (e.g., breast cancer) or active liver disease.
Restricted Use Women with an intact uterus must also use a progestogen.
Not Established Pediatric patients (children and adolescents).

Eligibility is defined by the absence of high-risk medical conditions and the use of the medicine within the specific postmenopausal female population. Use is strictly prohibited during pregnancy and in pediatric groups, as explicitly stated in the official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Divigel (estradiol transdermal gel) focuses on substances that can alter the systemic exposure of Estradiol by affecting its metabolism. The primary area of concern is pharmacokinetic interactions, which may cause circulating hormone levels to either increase or decrease.

Documented Pharmacokinetic Interaction Categories

Interaction Type Examples of Interacting Substances Official Effect on Estradiol Levels
Enzyme Inducers Phenobarbital, Rifampin, Carbamazepine, St. John's Wort May reduce plasma concentrations
Enzyme Inhibitors Ketoconazole, Erythromycin, Clarithromycin, Grapefruit Juice May increase plasma concentrations

These interactions are linked to the Cytochrome P450 3A4 (CYP3A4) enzyme, which plays a role in estrogen processing. Co-administration with enzyme inducers, which accelerate this pathway, may lead to lower Estradiol concentrations. Conversely, co-administration with inhibitors, which slow this pathway, may result in higher concentrations.

Specific medicines like certain anticonvulsants (e.g., carbamazepine) and antibiotics (e.g., clarithromycin) are documented to modify Estradiol exposure in this manner. The regulatory labeling does not identify any medicinal products that are formally contraindicated solely due to interaction risk.

Mechanism of Action

How Divigel Works

The active component, estradiol, exerts its pharmacological action by functioning as an agonist for the Estrogen Receptors (ERs), specifically ERalpha and ERbeta, found inside target cells. This molecular interaction triggers the genomic signaling pathway; the activated ER complex translocates into the nucleus and binds to Estrogen Response Elements (EREs) on DNA. This binding event regulates the transcription of specific genes, initiating a cascade that leads to the synthesis of distinct proteins.

This molecular activity influences several systems, notably by acting on ERs within the hypothalamus to modulate the thermal set point, thereby influencing the body's internal thermal regulation. Additionally, estradiol acts on cells within skeletal tissue, modulating the balance of the bone remodeling cycle (resorption and formation). This physiological effect influences the relationship between bone resorption and bone formation within the skeletal system.

Dosage and Administration Information

Divigel (estradiol gel) is intended for transdermal administration, requiring the application of a measured dose directly to the skin for systemic absorption. The usage pattern is a once-daily regimen, forming part of a continuous long-term plan, although the necessity of continued therapy must be periodically re-evaluated to maintain the lowest effective dose for the shortest duration.

The standard practice for initiating therapy is a starting daily dose of 0.25 grams of gel, containing 0.25 mg of estradiol. Based on the patient's clinical response, the dose may be adjusted (titrated) upward, with a maximum approved daily application of 1.25 grams.

Proper administration dictates that the gel is applied only to the upper thigh, alternating between the right and left thigh each day to minimize the risk of skin irritation. The application must cover a broad area, approximately 5 by 7 inches, and must be allowed to dry completely before the site is covered or touched. A key procedural condition is that the application site should not be washed for at least one hour after use to ensure proper drug delivery. Hand washing immediately after application is required to prevent unintended transference. For women who still have an intact uterus, the official usage protocol includes the mandatory co-administration of a progestin. If a dose is missed, the protocol involves applying it as soon as it is remembered, unless it is close to the next scheduled dose, in which case the missed dose is skipped; double dosing is prohibited.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Summary of Efficacy Studies

Research has explored outcomes related to vasomotor symptoms in postmenopausal women. The primary evidence is based on 12-week, double-blind, placebo-controlled trials. These studies investigated the transdermal application of estradiol gel, the active component of Divigel, at doses ranging from 0.25 mg to 1.0 mg per day.

  • Vasomotor Symptoms: In a pivotal Phase 3 trial, all three daily doses of the gel were reported to show a statistically significant reduction in the median daily frequency and severity of moderate to severe hot flashes compared to placebo by the study's end point. For the 1.0 mg dose, statistically significant differences were typically observed as early as Week 2.
  • Quality of Life: The clinical data from these studies examined patient-reported outcomes (PRO) and showed a corresponding change in quality of life indices related to menopausal symptoms.

Safety and Tolerability Findings

Across the clinical trials, the transdermal gel was generally reported to have an acceptable tolerability profile. Common adverse events (occurring in ge 5% of patients and greater than placebo) reported in the 12-week study included nasopharyngitis, upper respiratory tract infection, vaginal mycosis, and breast tenderness. The rate of discontinuation due to adverse events in these trials was reported as being low.

  • Transdermal Profile: Studies investigated the absorption profile of estradiol when the gel was administered on the thigh. Further research is ongoing to investigate the long-term safety profile and effects of extended use.

Comparative Studies

Research evaluated whether the estradiol gel, when compared to other transdermal estradiol preparations, showed a difference in measured endpoints. Findings from indirect network meta-analyses suggested that the highest dose (1.0 mg) was associated with the largest observed difference in the reduction of hot flash frequency, though this dose was also associated with a slightly higher risk of treatment-related adverse events.

Frequently Asked Questions (FAQ)

Common questions about Divigel (FAQ)


Q: How is Divigel different from estrogen pills?

Divigel is a transdermal gel, which means it’s applied directly to the skin for systemic delivery. This method of administration allows the active ingredient, Estradiol, to be absorbed into the bloodstream by bypassing the extensive initial processing (metabolism) that occurs when an estrogen pill is taken orally and passes through the liver.


Q: How quickly does Divigel start to work for symptoms?

Studies and official information indicate that for moderate-to-severe hot flashes (vasomotor symptoms), a statistically significant reduction in frequency and severity was typically observed as early as two weeks after starting treatment, especially with the higher doses. The time it takes for a full effect to be achieved may vary.


Q: What are the most common side effects of Divigel mentioned by users?

Adverse reactions documented in clinical trials that occurred commonly included breast tenderness, abnormal uterine bleeding (called metrorrhagia), and vaginal yeast infection (mycosis). Other common events included upper respiratory tract infections and nasopharyngitis.


Q: Can Divigel interact with common over-the-counter pain relievers?

Systemic Estradiol is known to have potential metabolic interactions with common substances, including some non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, which are often found in over-the-counter pain relievers. The potential effect of these substances is generally described in official sources as minor changes to the hormone's processing or activity.


Q: Does Divigel have any known cardiovascular risks?

Yes. As a systemic estrogen therapy, official regulatory warnings emphasize an increased potential for serious cardiovascular risks. These risks, identified in large-scale hormone replacement therapy studies, include stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and myocardial infarction (MI).


Q: Can Divigel interact with natural supplements like St. John's Wort?

Yes, regulatory documents list St. John's Wort as a supplement that can interact with Divigel. This supplement is documented as an enzyme inducer that may decrease the amount of Estradiol in the body by speeding up the way the body processes the hormone.


Q: What happens if you forget to apply Divigel one day?

If a dose is missed, official instructions advise applying it as soon as it is remembered, unless it is nearly time for the next scheduled dose. The next application is advised to occur at the regularly scheduled time. Applying a double dose to compensate for a missed dose is prohibited by regulatory instructions.


Q: What should be done if the gel is accidentally applied near the eyes?

Official patient instructions include a restriction to avoid contact of the gel with the eyes. If contact with the eyes occurs, patient instructions advise immediately washing the affected area.


Q: Is it necessary to use Divigel every day?

Yes, official prescribing information indicates that Divigel is intended for a continuous, long-term once-daily regimen. Consistent daily application is necessary for maintaining the therapeutic level described in clinical studies.


Q: Is there a generic version of Divigel available?

Yes, a generic version of Estradiol gel at the same concentration as Divigel is available for prescription. The availability of generic alternatives is determined by the FDA's approved drug list.


Q: How long does it take for Divigel to dry on the skin?

Divigel is described in official information as a quick-drying hydroalcoholic gel. Patient instructions advise allowing the gel to dry completely before getting dressed, covering the application site, or touching it. A specific, standardized drying time is not universally provided in the official label.


Q: Can men accidentally absorb Divigel if they touch the application area?

Regulatory documents include precautions regarding the potential for skin-to-skin transfer of the gel to others, which may result in unintended hormone exposure. It is officially instructed to wash hands after application and ensure the application site is covered after drying to prevent this transfer.


Q: Is it okay to use Divigel on different skin areas?

No. Proper administration dictates that the gel is applied only to the upper thigh, alternating between the right and left thigh each day. Official instructions prohibit application to other areas, including the face, breasts, or skin that is irritated or damaged.


Q: Does Divigel cause weight gain?

Weight gain is reported as a possible adverse effect that has been associated with the use of systemic estrogen-containing products. It is classified among the general side effects sometimes experienced by patients using this class of medication.


Q: Are there any specific foods or drinks to avoid while using Divigel?

Official information documents that Grapefruit Juice acts as an enzyme inhibitor and may increase the systemic exposure of Estradiol. In general, no other specific foods or drinks are formally prohibited from the diet in the regulatory label.


Q: Can Divigel affect sleep or mood?

Official adverse reaction reports and drug information suggest that symptoms related to mood changes, such as irritability or signs of depression (including poor concentration or changes in sleep), are sometimes reported as potential effects of estrogen therapy.


Q: Is it possible to have an allergic reaction to the gel or ingredients?

Yes. The official labeling states that the drug is contraindicated, meaning it must not be used, in individuals who are allergic to any of its ingredients. Serious allergic reactions, such as anaphylaxis (a severe, life-threatening allergic reaction), are listed among the potential risks associated with this drug class.


Q: What is the evidence for Divigel helping with vaginal dryness?

The active ingredient in Divigel, Estradiol, is approved to treat moderate-to-severe symptoms of vulvar and vaginal atrophy, which includes vaginal dryness, itching, and burning. However, the regulatory clinical trials often focus primarily on the efficacy for vasomotor symptoms (hot flashes).


Q: Can Divigel affect liver function?

Official documents state that Divigel is contraindicated in individuals with active liver disease. Signs of liver problems, such as yellowing of the skin or eyes, are listed among the serious potential adverse effects documented.


Q: Does using Divigel make skin more sensitive to the sun?

Drugs in the estrogen class may cause dark patches of skin on the face (called melasma). Therefore, official guidance often suggests avoiding excessive sun exposure, sunlamps, and tanning beds, and the use of sunscreen is recommended.


Q: Why is it important to rotate the application site of Divigel?

Official patient instructions recommend applying Divigel to the right or left upper thigh on alternating days. This rotation is specifically advised to minimize the risk of skin irritation at the application site over time.


Q: Can Divigel be used if a patient is also using other topical medications?

The official label advises caution regarding the application of other topical products on the same site. Studies involving similar estrogen products have shown that sunscreens and other lotions applied to the skin have the potential to change the systemic absorption and exposure of the topically applied estrogen.


Q: What is the difference between Divigel and other estrogen gels?

Divigel is distinguished by its unique formulation and recommended use: it is applied once daily to the upper thigh over a relatively small area. Other estrogen gels may differ in their application site, the required frequency of use, or the size of the application surface area, as described in their individual regulatory labels.


Q: Is it normal to feel localized irritation where Divigel is applied?

The need to rotate the application site is mentioned in regulatory documents specifically to minimize the risk of skin irritation. This indicates that while not always expected, localized irritation or redness where the gel is applied is a possibility that some patients may experience.


Q: Can Divigel be used after menopause has been established for many years?

The medication is officially approved for use in adult postmenopausal women, regardless of how long menopause has been established. Clinical analyses reviewed in regulatory documents included postmenopausal women across a wide range of ages.


Q: What happens if a pet licks the application site of Divigel?

The FDA has issued warnings concerning accidental exposure of pets, particularly dogs, to estrogen gel products, which can lead to adverse effects in the animals. The precautions for preventing transference to others apply equally to preventing exposure to pets.


Q: Can Divigel interact with medications for thyroid problems?

Estrogen-containing products are documented to affect thyroid function tests. Official information notes that patients using thyroid hormone replacement therapy may experience a need for dose adjustment, according to information for healthcare providers.


Q: What is the purpose of the alcohol in the Divigel formulation?

Divigel is formulated in a fast-drying hydroalcoholic gel base. The alcohol (ethanol) in the formulation serves as a solvent and a penetration enhancer to facilitate the absorption of the active ingredient, Estradiol, through the skin for systemic delivery.


Q: Can Divigel be transferred to clothing after it dries?

Regulatory instructions advise allowing the gel to dry completely before covering the application site with clothing to prevent unintended transference. This suggests that once completely dry, the risk of transference to others via clothing is reduced.


Q: Is it possible to swim or shower shortly after applying Divigel?

No. Official patient instructions stipulate that the application site should not be washed for at least one hour after applying Divigel. This time frame is specified to ensure proper drug delivery and adequate absorption.


Q: Why is a specific dose recommended for the start of treatment?

The standard practice for initiating therapy is a specified starting daily dose. This dose is typically chosen to achieve the lowest effective therapeutic level of estrogen, which can then be adjusted (or titrated) upward or downward based on the patient's specific clinical response.


Q: Are there official guidelines on how long treatment with Divigel should last?

Official guidance emphasizes that treatment should use the lowest effective dose for the shortest duration necessary to achieve the treatment goals. The necessity of continued therapy must be periodically re-evaluated by a healthcare provider.

How should Divigel be stored and disposed of?

How to Store and Dispose of Divigel

The storage and disposal of Divigel (estradiol transdermal gel) must strictly follow the official conditions outlined in regulatory labeling.


Storage Requirements

Divigel must be kept at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted excursions up to 30 C. The gel is flammable; therefore, it must be stored and handled away from heat and open flame or other ignition sources. The medication must be kept in its original container and stored out of the reach of children.

Disposal Instructions

Empty, used unit-dose packets should be disposed of in the household trash. Any unused or expired Divigel should be discarded through an authorized drug take-back program or by following local official guidelines for drug disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Divigel found in:

A-Z Index: